Table 1.
Information about the monoclonal antibodies used in this study
| Antibody | Epitope | Structure and amino acid sequence | Isotypes | Reference |
|---|---|---|---|---|
| CIIC1 | CII (C1) | 358–369: GARGLTGRPGDA | IgG2a | [17] |
| CIIC2 | CII (D3) | 687–698: RGAQGPPGATGF | IgG2b | [17] |
| UL1 | CII (U1) | 494–504: LVGPRGERGFP | IgG2b | [31] |
| M2139 | CII (J1) | 551–564: MPGERRGAAGIAGPK | IgG2b | [32] |
| L10D9 | CXI (D3) | IgG2a | [28] | |
| 15A11 | COMP | EGF-repeat 4: PSPCHEKADCILERDGSRS | IgG1 | [25] |
| ACC1 | CII (CitC1) | CII121-144, CII241-264, CII571-591, CII 916-939 (F4 epitope), CII931-954, C1 (C1-T-CIT365), F4 (F4-T-CIT933), CII571-591 | IgG2a | [23] |
| L243 | Anti-HLA DR antibody | IgG2a | ATCC® HB-55™ | |
| G11 | Anti-human parathyroid cells antibody | IgG2b | [33] | |
| Hy2.15 | Anti-hapten antibody | IgG1 | [34] |
All epitopes are in native triple helical form; amino acids are abbreviated as follows: G glycine, P proline or hydroxyproline, E glutamic acid, R arginine, K lysine, H histidine, F phenylalanine, A alanine, L leucine, T threonine, Y tyrosine